Herbalife Ltd. files DEF 14A for the fiscal year ending December 31, 2023.

Ticker: HLF · Form: DEF 14A · Filed: Mar 12, 2024 · CIK: 1180262

Herbalife LTD. DEF 14A Filing Summary
FieldDetail
CompanyHerbalife LTD. (HLF)
Form TypeDEF 14A
Filed DateMar 12, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$120,000, $1 m, $75,000
Sentimentneutral

Sentiment: neutral

Topics: Herbalife, DEF 14A, Executive Compensation, Stock Awards, SEC Filing

TL;DR

<b>Herbalife Ltd. has filed its DEF 14A for the fiscal year ending December 31, 2023, detailing executive compensation and historical company name changes.</b>

AI Summary

HERBALIFE LTD. (HLF) filed a Proxy Statement (DEF 14A) with the SEC on March 12, 2024. Herbalife Ltd. filed a DEF 14A with the SEC on March 12, 2024. The filing covers the fiscal year ending December 31, 2023. The company's previous name was Herbalife Nutrition Ltd. until April 24, 2018. Herbalife Ltd. was formerly known as WH Holdings Cayman Islands Ltd. until August 14, 2002. The filing includes details on executive compensation and stock awards for members like Johnson and Dr. John Agwunobi.

Why It Matters

For investors and stakeholders tracking HERBALIFE LTD., this filing contains several important signals. This DEF 14A filing provides crucial information regarding executive compensation, stock awards, and the fair value calculations associated with these awards for the fiscal year 2023. The document also serves as a record of the company's corporate history, including previous name changes, which can be relevant for understanding its evolution and potential legacy issues.

Risk Assessment

Risk Level: low — HERBALIFE LTD. shows low risk based on this filing. The filing is a routine DEF 14A, which is a standard disclosure for public companies regarding executive compensation and annual meetings, posing no immediate new risks.

Analyst Insight

Review the executive compensation details and stock award valuations to understand potential incentives and their impact on future performance.

Key Numbers

Key Players & Entities

FAQ

When did HERBALIFE LTD. file this DEF 14A?

HERBALIFE LTD. filed this Proxy Statement (DEF 14A) with the SEC on March 12, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by HERBALIFE LTD. (HLF).

Where can I read the original DEF 14A filing from HERBALIFE LTD.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HERBALIFE LTD..

What are the key takeaways from HERBALIFE LTD.'s DEF 14A?

HERBALIFE LTD. filed this DEF 14A on March 12, 2024. Key takeaways: Herbalife Ltd. filed a DEF 14A with the SEC on March 12, 2024.. The filing covers the fiscal year ending December 31, 2023.. The company's previous name was Herbalife Nutrition Ltd. until April 24, 2018..

Is HERBALIFE LTD. a risky investment based on this filing?

Based on this DEF 14A, HERBALIFE LTD. presents a relatively low-risk profile. The filing is a routine DEF 14A, which is a standard disclosure for public companies regarding executive compensation and annual meetings, posing no immediate new risks.

What should investors do after reading HERBALIFE LTD.'s DEF 14A?

Review the executive compensation details and stock award valuations to understand potential incentives and their impact on future performance. The overall sentiment from this filing is neutral.

How does HERBALIFE LTD. compare to its industry peers?

Herbalife Ltd. operates in the wholesale of drugs, proprietaries, and druggists' sundries.

Are there regulatory concerns for HERBALIFE LTD.?

The filing is a DEF 14A, a standard disclosure under the Securities Exchange Act of 1934.

Industry Context

Herbalife Ltd. operates in the wholesale of drugs, proprietaries, and druggists' sundries.

Regulatory Implications

The filing is a DEF 14A, a standard disclosure under the Securities Exchange Act of 1934.

What Investors Should Do

  1. Analyze the executive compensation packages disclosed in the DEF 14A.
  2. Examine the details of stock awards and their valuation methods.
  3. Note the historical company name changes for corporate context.

Year-Over-Year Comparison

This is the initial DEF 14A filing for the fiscal year ending December 31, 2023, following previous filings for earlier periods.

Filing Stats: 4,590 words · 18 min read · ~15 pages · Grade level 13.7 · Accepted 2024-03-12 16:29:47

Key Financial Figures

Filing Documents

Executive Compensation Highlights

Executive Compensation Highlights Incentive design links pay outcomes to Company share price performance and against preset goals Balanced mix between fixed and variable compensation and short- and long-term incentives Annual say-on-pay advisory vote Compensation risk assessment Robust share ownership guidelines for named executive officers "Double trigger" change in control Clawback policy applicable to Section 16 officers applicable to cash and equity incentives Anti-hedging and anti-pledging policies applicable to all employees This proxy statement includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current facts, including statements regarding our environmental and other sustainability plans and goals, made in this document are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management's current expectations and are inherently uncertain. Actual results or outcomes could differ materially for a variety of reasons. Risks and uncertainties that could cause our actual results to differ significantly from management's expectations are described in our 2023 Annual Report on Form 10-K. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. Website references throughout this document are provided for convenience only, and the content on the referenced websites is not incorporated by reference into this document. Proxy summary Table of Contents Proxy Statement table of contents Part 1. Our annual general meeting of shareholders Information concerning solicitation and voting 1

Executive compensation program objectives

Executive compensation program objectives 40 Elements of Compensation 42 Establishing CEO compensation 42 Role of executive officers in executive compensation decisions 42 Base salaries 43 Annual incentive awards 43 Targets and award determination 44 Long-term incentive awards 46 2023 Long-term incentive awards – annual grant program 46 Equity award grant policy 47 Hedging 47 Pledging 47 Clawback policy 47 Benefits and perquisites 47 Employment and severance agreements 48 Compensation advisor 49 Peer Group 49 Tax implications 51 Compensation Committee report 51 Executive officers of the registrant 51 2023 Summary compensation table 52 2023 Grants of plan-based awards 53 Narrative disclosure to summary compensation table and grants of plan-based awards 54 Outstanding equity awards at 2023 fiscal year-end 55 i Table of Contents 2023 Option exercises and stock vested 56 2023 Non-qualified deferred compensation table 56 Potential payments upon termination or change in control 57 Pay ratio disclosure 61 Pay v. Performance 62 Part 5. Security ownership of certain beneficial owners and management Beneficial ownership 66 Part 6. Certain relationships and related transactions Ongoing related party transactions 68 Other transactions 69 Part 7. Additional information "Householding" of proxy materials 70 Shareholder nominations 70 Shareholder proposals for the 2025 annual general meeting 71 Codes of conduct and principles of corporate governance 71 Annual report, financial and additional information 71 Other matters 72 ii Table of Contents Table of Contents Part 1 Our annual general meeting of shareholders Information concerning solicitation and voting Place, time and date of meeting. This Proxy Statement is being furnished to the Company's shareholders in connection with the solicitation of proxies on beha

: Approve, on an advisory basis, the compensation of the Company's named executive officers

Item 2: Approve, on an advisory basis, the compensation of the Company's named executive officers For, Against or Abstain FOR Majority of shares represented in person or by proxy and entitled to vote and which do vote No effect No effect Item 3: Approve an amendment and restatement of the Company's 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan For, Against or Abstain FOR Majority of shares represented in person or by proxy and entitled to vote and which do vote No effect No effect Item 4: Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2024 For, Against or Abstain FOR Majority of shares represented in person or by proxy and entitled to vote and which do vote No effect Brokers have discretion to vote YOUR VOTE IS VERY IMPORTANT. Whether or not you plan to attend the Meeting, please take the time to vote. You may vote your shares via a toll-free telephone number, over the Internet or by completing, signing and mailing the proxy card or voting instruction form provided to you. Please follow the instructions on the proxy card or voting instruction form. Revocability of proxies. Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before its use by either: (a) delivering to the Corporate Secretary of the Company a written notice of revocation or a duly executed proxy bearing a later date; (b) granting a subsequent proxy through the Internet or telephone; or (c) attending the Meeting and voting in person. However, please note that if you would like to vote at the Meeting and you are not the shareholder of record, you must request, complete and deliver a proxy from your broker or other nominee. Proxy solicitation. The Company bears the expense of printing and mailing proxy materials. Proxies may be solicited by certain of our directors, of

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing